Kapil Meleveedu
@hematologymd.bsky.social
Asst Prof, Director Transplant and Cell Therapy, Malignant hematology head. Physician entrepreneur. Interested in Stem cells, myeloid and all things 🩸
Pinned
Kapil Meleveedu
@hematologymd.bsky.social
· Dec 21
Bone Marrow Transplant Team Provides Lifesaving Care for German Patient with Rare Brain Cancer - UConn Today
As the couple prepares to head back to Germany, they say they will always consider UConn Health their second home
today.uconn.edu
A team that is incredibly passionate and tireless.A leadership that’s phenomenal and visionary. United in a common mission to offer hope and bring smiles.A success story of possibilities and resilience on the anniversary of our new BMT program and honored to lead it!
today.uconn.edu/2024/12/bone...
today.uconn.edu/2024/12/bone...
Four fold increase in risk of infectious complications after stem cell transplant with oral mucositis than without.
www.mdpi.com/2072-6694/17...
www.mdpi.com/2072-6694/17...
www.mdpi.com
August 15, 2025 at 12:25 PM
Four fold increase in risk of infectious complications after stem cell transplant with oral mucositis than without.
www.mdpi.com/2072-6694/17...
www.mdpi.com/2072-6694/17...
STOP CAR, ON CAR, OFF CAR, SNIP(er) and VIPER(s) and many other strategies!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Novel strategies to manage CAR-T cell toxicity - Nature Reviews Drug Discovery
Treatment with chimeric antigen receptor (CAR)-T cell therapies is associated with important immune-related adverse events. In this Review, the authors discuss the standard-of-care management for...
www.nature.com
February 18, 2025 at 12:48 PM
STOP CAR, ON CAR, OFF CAR, SNIP(er) and VIPER(s) and many other strategies!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Although very rare, some brakes needed for the CARs
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53 | NEJM
Malignant T-cell transformation after chimeric antigen receptor (CAR) T-cell therapy
has been described, but the contribution of CAR integration to oncogenesis is not
clear. Here we report a case o...
www.nejm.org
February 6, 2025 at 3:52 AM
Although very rare, some brakes needed for the CARs
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
A team that is incredibly passionate and tireless.A leadership that’s phenomenal and visionary. United in a common mission to offer hope and bring smiles.A success story of possibilities and resilience on the anniversary of our new BMT program and honored to lead it!
today.uconn.edu/2024/12/bone...
today.uconn.edu/2024/12/bone...
Bone Marrow Transplant Team Provides Lifesaving Care for German Patient with Rare Brain Cancer - UConn Today
As the couple prepares to head back to Germany, they say they will always consider UConn Health their second home
today.uconn.edu
December 21, 2024 at 9:53 PM
A team that is incredibly passionate and tireless.A leadership that’s phenomenal and visionary. United in a common mission to offer hope and bring smiles.A success story of possibilities and resilience on the anniversary of our new BMT program and honored to lead it!
today.uconn.edu/2024/12/bone...
today.uconn.edu/2024/12/bone...
December 14, 2024 at 10:05 PM
Sun. Fog. Dusk. Dawn
Science and research
Dibble dibble dibble dopp
🩸🩸🩸
#ASHaiku #ASH24
@ash-hematology.bsky.social
Science and research
Dibble dibble dibble dopp
🩸🩸🩸
#ASHaiku #ASH24
@ash-hematology.bsky.social
December 8, 2024 at 3:20 PM
Sun. Fog. Dusk. Dawn
Science and research
Dibble dibble dibble dopp
🩸🩸🩸
#ASHaiku #ASH24
@ash-hematology.bsky.social
Science and research
Dibble dibble dibble dopp
🩸🩸🩸
#ASHaiku #ASH24
@ash-hematology.bsky.social
December 8, 2024 at 5:18 AM
Thanks to @ash-hematology.bsky.social for this feed to catch up #ASH24 in one place! No more FOMO for virtual attendees ✋🏽
December 7, 2024 at 3:39 PM
Thanks to @ash-hematology.bsky.social for this feed to catch up #ASH24 in one place! No more FOMO for virtual attendees ✋🏽
Reposted by Kapil Meleveedu
Today’s poem is called ‘Needles’.
December 7, 2024 at 8:46 AM
Today’s poem is called ‘Needles’.
We are hiring ! Looking for a BMT/cell therapy RN for our growing new BMT program. Check out the link - 'Join Our Team today' and scroll to page two for more details or DM me if anyone is interested.
health.uconn.edu/jobs
health.uconn.edu/jobs
Jobs | UConn Health
Nursing Careers If you want to be part of a team where nurses are respected, valued, and encouraged to learn and grow, you want to be a nurse at UConn Healt ...
health.uconn.edu
December 6, 2024 at 2:28 PM
We are hiring ! Looking for a BMT/cell therapy RN for our growing new BMT program. Check out the link - 'Join Our Team today' and scroll to page two for more details or DM me if anyone is interested.
health.uconn.edu/jobs
health.uconn.edu/jobs
December 3, 2024 at 12:17 PM
Reposted by Kapil Meleveedu
An excellent review characterizing the role of imetelstat in lower-risk MDS!
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
November 27, 2024 at 9:00 PM
An excellent review characterizing the role of imetelstat in lower-risk MDS!
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
ECOG-ACRIN 4151: MCL pts in CR1 with undetectable MRD6 did not benefit from consolidative auto-HCT. Pts who remain MRD+ after induction may benefit from auto-HCT. LBA #ASH24
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
Paper: Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Dise...
ash.confex.com
November 25, 2024 at 11:17 PM
ECOG-ACRIN 4151: MCL pts in CR1 with undetectable MRD6 did not benefit from consolidative auto-HCT. Pts who remain MRD+ after induction may benefit from auto-HCT. LBA #ASH24
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
Reposted by Kapil Meleveedu
If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW
November 22, 2024 at 2:33 PM
If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW
4-gene prognostic risk classifier (FLT3-ITD, KRAS, NRAS, and TP53) seems to successfully differentiate outcomes among patients with newly diagnosed AML treated with Aza/Ven than ELN 2017/2022
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
November 22, 2024 at 6:38 PM
4-gene prognostic risk classifier (FLT3-ITD, KRAS, NRAS, and TP53) seems to successfully differentiate outcomes among patients with newly diagnosed AML treated with Aza/Ven than ELN 2017/2022
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Ph 1 CD7 targeted CAR for R/R AML. Great CR rate (70%) in extensively treated pts. But short DoR without alloSCT. Relapse with CD7 loss
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
November 20, 2024 at 2:48 PM
Ph 1 CD7 targeted CAR for R/R AML. Great CR rate (70%) in extensively treated pts. But short DoR without alloSCT. Relapse with CD7 loss
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
November 20, 2024 at 1:08 AM
November 18, 2024 at 3:03 AM
Acute myelopathy following CAR-T
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
November 17, 2024 at 6:41 PM
Acute myelopathy following CAR-T
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Exciting to see #cell therapy #CAR-T making in roads in non-oncology conditions
CAR-T for autoimmune disorders
www.science.org/content/arti...
CAR-T for autoimmune disorders
www.science.org/content/arti...
A breakthrough cancer immunotherapy is now taking aim at autoimmune disease
CAR-T therapy is generating excitement for lupus, scleroderma, and other conditions as clinical trials expand
www.science.org
November 17, 2024 at 12:58 AM
Exciting to see #cell therapy #CAR-T making in roads in non-oncology conditions
CAR-T for autoimmune disorders
www.science.org/content/arti...
CAR-T for autoimmune disorders
www.science.org/content/arti...